Oruka Therapeutics, Inc. · NASDAQ:ORKA
Agarwal Arjun sold 10,019 Oruka Therapeutics, Inc. shares (Form 4)
Traded Sep 11 to Sep 15, 2026 · Filed Sep 15, 2026
From Sep 11 to Sep 15, 2026, Agarwal Arjun (Senior Vice President, Finance) sold 10,019 Oruka Therapeutics, Inc. shares at an average US$92.42 for US$926K under a trading plan, leaving 14,752 shares. Filed Sep 15, 2026 (Form 4).
- Sold
- 10,019 shares
- Price
- US$92.42 average (US$91.11 to US$95.71)
- Value
- US$926K
- Holding after
- 14,752 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Senior Vice President, Finance
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 11, 2026 | Common Stock | Option exercise | 8,000 | US$12.50 | 23,312 | Direct |
| Sep 11, 2026 | Common Stock | Option exercise | 1,459 | US$34.39 | 24,771 | Direct |
| Sep 11, 2026 | Common Stock | Sale | 3,000 | US$91.11 | 21,771 | Direct |
| Sep 11, 2026 | Common Stock | Sale | 4,051 | US$92.41 | 17,720 | Direct |
| Sep 11, 2026 | Common Stock | Sale | 2,208 | US$93.26 | 15,512 | Direct |
| Sep 11, 2026 | Common Stock | Sale | 200 | US$94.02 | 15,312 | Direct |
| Sep 15, 2026 | Common Stock | Sale | 560 | US$95.71 | 14,752 | Direct |
Source
Related
- Oruka Therapeutics, Inc.
- Agarwal Arjun
- Oruka Therapeutics, Inc. shareholders
- Form 4 · Agarwal Arjun · Oct 13, 2026
- Form 4 · Agarwal Arjun · Sep 21, 2026
- Form 4 · Agarwal Arjun · Aug 14, 2026
- Form 4 · Agarwal Arjun · Jul 13, 2026
- Form 4 · Agarwal Arjun · Jun 22, 2026
- Form 4 · Quinlan Paul T · Oct 20, 2026
- Form 4 · Goncalves Joana · Oct 15, 2026
- Form 4 · Klein Lawrence Otto · Oct 2, 2026
- Form 4 · Quinlan Paul T · Sep 21, 2026
- Form 4 · Goncalves Joana · Sep 15, 2026